TRIM59 and cancer: High TRIM59 expression is significantly associated with a worse prognosis in kidney renal papillary cell carcinoma (KIRP), liver hepatocellular carcinoma (LIHC), and lung adenocarcinoma (LUAD), and it was also associated with various clinicopathological factors in BRCA, ESCA, LUSC, STAD, and immune markers across all these cancers.